INSYS THERAPEUTICS INC NEW's ticker is and the CUSIP is 45824V959. A total of 3 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $153,000 | -13.6% | 11,800 | +6.3% | 0.00% | – |
Q1 2016 | $177,000 | -86.5% | 11,100 | -75.8% | 0.00% | -100.0% |
Q4 2015 | $1,311,000 | +113.2% | 45,800 | +112.0% | 0.00% | 0.0% |
Q3 2015 | $615,000 | -67.8% | 21,600 | -59.3% | 0.00% | -50.0% |
Q2 2015 | $1,907,000 | +73.5% | 53,100 | +181.0% | 0.00% | +100.0% |
Q1 2015 | $1,099,000 | +103.5% | 18,900 | +47.7% | 0.00% | 0.0% |
Q4 2014 | $540,000 | +4.7% | 12,800 | -3.8% | 0.00% | 0.0% |
Q3 2014 | $516,000 | +218.5% | 13,300 | +155.8% | 0.00% | – |
Q2 2014 | $162,000 | – | 5,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Citadel Advisors | 12,800 | $540,000 | 0.00% |
GROUP ONE TRADING, L.P. | 300 | $13,000 | 0.00% |
SIMPLEX TRADING, LLC | 1 | $0 | 0.00% |